PGEN Precigen, Inc.
PGEN Precigen, Inc.
Healthcare · Biotechnology
Market read
Scan convergence 1 scan as of 2026-10-16 1 neutral converging
POC $4.15 · VWAP $5.03 · +26.9% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster COO, Director + 1 other sold $2.3M, Aug 25–28
Coverage
1 watchlist
PGEN Price Structure
Loading timeframes…
Peers
Every watchlist PGEN belongs to, members best 30-day change first — PGEN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Against street estimates
How PGEN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about PGEN from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled today · Oct 17
- Precigen (PGEN) Q2 2026 Earnings Report - TipRanks
- PGEN Stock | Precigen, Inc. Price, Quote, News & Analysis
- Press Releases - Precigen
- Earnings Beat: Precigen, Inc. (NASDAQ:PGEN) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
- Precigen (PGEN) Q4 2025 Earnings Results & Call Transcript
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
PGEN research tape
3 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.